XXSS
GENERIC MADRID TRANSACTION SENT TO IB
08/18/2026
Back to search
Official data from USPTO
LIAISON MDX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
LIAISON MDX
ST13
US500000079227875Class
5, 9, 10
Filing
79227875
Registration
5658530
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
38
Latest update
08/18/2026
Trademark type
Word
Nice classes
5, 9, 10
Filing date
07/28/2017
Registration date
01/22/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/14/2025
Last transaction
08/18/2026
Responsible office
United States Patent and Trademark Office
Status code
708
Official register
Principal Register
Drawing code
4
Owner type
09
Owner location
SALUGGIA, VERCELLI, IT
Examiner
NEHMER, JASON ROBERT
Current location
Historical data usage
Holders and representatives
Holders
DIASORIN S.P.A.
DIASORIN S.P.A.
Representatives
Jeffrey B. Sladkus, Esq. THE SLADKUS LAW GROUP
Technical classification
Nice Classes
Class 5Class 9Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Diagnostic preparations for medical purposes; diagnostic materials in the nature of medical diagnostic reagents and assays for extractiontesting and analysis of bodily fluidsextraction of viral nucleic acidbacterial nucleic acidstool DNAblood DNARNAfor the extraction and isolation of blood cells; preparations for use in medical diagnostic tests; chemical preparations for testing blood for medical purposes; chemical preparations for testing blood for veterinary purposes; in vitro diagnostic preparations for medical purposes; in vitro diagnostic preparations for veterinary purposes; chemicals for medical use for testing DNA; nucleic acid sequences for medical and veterinary purposes; reagents for use in diagnostic tests for medical purposes; reagents for use in diagnostic tests for veterinary purposes; reactants for medical diagnosis; diagnostic reagents for medical use; diagnostic biomarker reagents for medical purposes; diagnostic biomarker reagents for veterinary purposes; diagnostic substances for medical use; diagnostic substances for veterinary use; antiserums for diagnostic purposes; chemical test reagents for medical use; chemical test reagents for veterinary use; reagents for microbiological analysis for medical purposes; reagents for microbiological analysis for veterinary purposes; reagents for use with analyzers for medical purposes; reagents for use with analyzers for veterinary purposes; diagnostic chemical reagents for medical use; diagnostic chemical reagents for veterinary use; medical diagnostic reagents and assays for testing of body fluids; diagnostic agents for pharmaceutical use; test strips for measuring blood glucose levels; medical diagnostic test strips; chemical diagnostic reagents for medical use for extractingtesting and analyzing body fluidsnucleic acidsDNARNA; chemical diagnostic reagents for medical use for extractingisolatingtesting and analyzing body fluids
Class 9
Scientific apparatus and instrumentsmolecular biological and immunological testing systemsmicroarray scannersDNA and protein chipskits for multiplex polymerase chain reaction (PCR) tests consisting primarily of optical and electronic apparatus for analyzing biological or biochemical sampleselectrophoresis apparatusnucleic acid and protein sequencing apparatuspolymerase chain reaction (PCR) thermal cyclersincluding associated hardware and software therefor and also containing devices for removingmarkingapplying and identifying biological or biochemical samplespipettescannulae; diagnostic testing apparatus for scientific and research testing of biological or biochemical sampleselectrophoresis apparatusnucleic acid and protein sequencing apparatuspolymerase chain reaction (PCR) thermal cyclers; computer systems and software for collectingstoringanalysing and reporting biological informationfor sample tracking and managing projectslaboratory workflows and datafor use in the fields of scientificdiagnostic and clinical research and for clinical diagnostic purposes; software for electronic medical and diagnostic apparatus; softwaredatabanks and computer programs containing algorithms for helping to make medical decisions or carry out researchfor diagnostic and therapeutic applications; Computer hardware for medical and diagnostic tasks; devices for generating images for detectingquantifying and linking biological or chemical molecules; laboratory instrumentsgenome sequencers; devices for generating imagesfluorimeters used to register fluorescence signals and produce data
Class 10
Test kits for clinical medical use comprising test tubestest plates and indicator diagrams for evaluating test results; apparatus for carrying out medical diagnosesfluorescence diagnostic apparatus and instruments used for the purpose of identifying infectious diseases and the severity thereof; diagnostic imaging apparatus for medical use; diagnostic lasers for medical use; medical and diagnostic devicesapparatus and equipment for molecular analysis; scanners for medical diagnosis; spectrum analyzers for use in medical diagnosis; Ultrasonic medical diagnostic apparatus being sources of ultrasonic fields for use in medical diagnosis; Magnetic apparatus being sources of magnetic fields for use in medical diagnosis; Electromagnetic medical diagnostic imaging apparatus being sources of electromagnetic fields for use in medical diagnosis; optical instruments for medical diagnostics; containers for disposal of medical instrumentsmedical samplessyringes and plungers; Medical sampling vials of plastic or other materials for containing medical samples; Medical preparation vials of plastic or other materials for preparation of medical samples; diagnostic testing instruments for medical purposeselectrical laboratory diagnostic instruments for the analysis of nucleic acids and proteins for medical use; diagnostic kits consisting primarily of electronic instruments for medical diagnosis and analysis of body fluidstissuesbiomoleculesDNAantibodiesproteinsmolecular material or cellular material; scientific apparatus for diagnostic testing of biological samples medical use; medical specimen cups
Publications
History of USPTO decisions and trademark events.
38 publications found
XXCR
GENERIC MADRID TRANSACTION CREATED
08/18/2026
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
01/14/2026
NA75
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
05/14/2025
C75P
REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
05/14/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/13/2025
ES75
TEAS SECTION 71 & 15 RECEIVED
01/14/2025
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
01/22/2024
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
06/01/2019
FICS
FINAL DISPOSITION NOTICE SENT TO IB
05/09/2019
FIMP
FINAL DISPOSITION PROCESSED
05/09/2019
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
04/22/2019
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/15/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
01/22/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/06/2018
PUBO
PUBLISHED FOR OPPOSITION
11/06/2018
GPNX
NOTIFICATION PROCESSED BY IB
11/02/2018
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
10/17/2018
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
10/17/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/17/2018
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
09/28/2018
ALIE
ASSIGNED TO LIE
09/28/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/18/2018
XAEC
EXAMINER'S AMENDMENT ENTERED
09/18/2018
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
09/18/2018
GNEA
EXAMINERS AMENDMENT E-MAILED
09/18/2018
CNEA
EXAMINERS AMENDMENT -WRITTEN
09/18/2018
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/05/2018
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/05/2018
RFNT
REFUSAL PROCESSED BY IB
04/06/2018
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/19/2018
RFRR
REFUSAL PROCESSED BY MPU
03/19/2018
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/13/2018
CNRT
NON-FINAL ACTION WRITTEN
03/12/2018
MAFR
APPLICATION FILING RECEIPT MAILED
03/09/2018
DOCK
ASSIGNED TO EXAMINER
03/05/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/05/2018
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
03/01/2018
Continuous trademark protection
Get notified about every new filing that threatens LIAISON MDX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.